ClinicalTrials.Veeva

Menu

Progressive Resistance Training for Adults With External Snapping Hip (Snappy Hip)

A

Aarhus University Hospital

Status

Enrolling

Conditions

Coxa Saltans External
External Snapping Hip

Treatments

Behavioral: Waiting time
Behavioral: Self guided exercise
Other: Progressive resistance training

Study type

Interventional

Funder types

Other

Identifiers

NCT06924164
Snappy Hip Tirial
4308-00012B (Other Grant/Funding Number)

Details and patient eligibility

About

External snapping hip is characterised by an audible and painful snap during hip movement among physical active people around 15-40 years old. Progressive resistance training has been suggested as a new potential treatment path in treating patients with external snapping hip. The investigators conducted a feasibility study and found that patients reported less pain and improved their physical function, quality of life and muscle strength after 12 weeks of progressive resistance training. The overall aim of the project is to compare hip pain in patients with external snapping hip treated with progressive resistance training to a wait-and-see approach, in a randomised controlled trial. This study has the potential to establish a new and specific treatment option for patients with external snapping hip, to be used nationally and internationally.

Full description

This trial is an international multicentre randomised controlled assessor-blinded crossover trial, following the CONSORT guidelines. The intervention is a 12-week progressive resistance training programme, and the trial is designed with three follow-up time points. After the baseline test, the patients will be randomised in a 1:1 ratio to either the intervention or the control group using the Research Electronic Data Capture (REDCap) source hosted at Aarhus University. For both groups, the first test will be the baseline test, conducted before the randomisation. The second test will be conducted 6 weeks after randomisation, the third test will be conducted 12 weeks after randomisation and the fourth and last test will be conducted 24 weeks after randomisation. The primary outcome will be the change from baseline to the third follow-up, and the trial will be powered based on this period. The lasting effect of the intervention will be evaluated from baseline to the fourth follow-up test for the intervention group.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-40 years (10)
  • Experienced lateral hip joint "snapping" with pain discomfort within the last 14 days
  • Able to demonstrate the audible and/or visible lateral "snapping" during lateral hip joint movementor popping sound when the hip joint moves
  • Capable of commuting to the training facility
  • Proficient in reading and understanding Danish or English

Exclusion criteria

  • Previous surgery on the affected hip
  • Planned surgery on lower extremities within the trial period
  • Anterior or medial hip discomfort that substantially exceeds the lateral hip discomfort
  • Any contraindication to exercise
  • Neurological, rheumatoid, or mental conditions affecting the hip function
  • Ongoing active cancer treatment
  • Planned vacation for more than 14 days within the intervention period
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

100 participants in 2 patient groups

Control group: Wait and see approach
Other group
Description:
The control group are randomized to 12 weeks of waiting time followed by 12 weeks of progressive resistance training.
Treatment:
Other: Progressive resistance training
Behavioral: Waiting time
Intervention group: progressive resistance training
Experimental group
Description:
The intervention group are randomized to 12 weeks of progressive resistance training followed by 12 weeks of self guided exercise
Treatment:
Other: Progressive resistance training
Behavioral: Self guided exercise

Trial contacts and locations

13

Loading...

Central trial contact

Inger Mechlenburg, DMSc; Lisa U Tønning, MHSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems